Furthermore, our findings highlight the need for further basic and translational research to elucidate the mechanistic pathways by which GDF15 influences PAD pathophysiology, which may facilitate the development of novel targeted therapies to improve limb outcomes. The gene discussed is GDF15; the disease is peripheral arterial disease.